13D/13G Filings - Nant Capital, LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-04-24
8:02 pm
Purchase
2025-04-22 13D Panbela Therapeutics, Inc.
PBLA
Nant Capital, LLC 32,432,432
86.980%
30,005,366increase
(+1236.28%)
Filing
History
2024-10-29
7:40 pm
Purchase
2024-10-22 13D Panbela Therapeutics, Inc.
PBLA
Nant Capital, LLC 2,427,066
33.330%
2,427,066increase
(New Position)
Filing
History
2023-09-07
5:27 pm
Purchase
2023-08-28 13D NantHealth, Inc.
NHIQ
Nant Capital, LLC 24,027,343
77.310%
24,027,343increase
(New Position)
Filing
History
2023-06-16
9:15 pm
Purchase
2023-06-07 13G Heliogen, Inc.
HLGN
Nant Capital, LLC 978,482
17.400%
245,397increase
(+33.47%)
Filing
History
2022-02-23
5:11 pm
Purchase
2021-12-31 13G Heliogen, Inc.
HLGN
Nant Capital, LLC 733,085
14.000%
733,085increase
(New Position)
Filing
History